Brief Title
Expanded Access to Velmanase Alfa
Brief Summary
Individual patient expanded access requests may be considered for patients who have no other treatment options.
Detailed Description
Expanded access may provide access for treatment prior to approval by the local regulatory agency.
Study Type
Expanded Access
Condition
Alpha-Mannosidosis
Intervention
Velmanase Alfa
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Drug
Eligibility Criteria
Inclusion Criteria: - Exclusion Criteria: -
Gender
All
Ages
N/A - N/A
Contacts
, (888) 661-9260, [email protected]
Administrative Informations
NCT ID
NCT04959240
Organization ID
Velmanase alfa-EAP
Responsible Party
Sponsor
Study Sponsor
Chiesi Farmaceutici S.p.A.
Study Sponsor
, ,
Verification Date
July 2021